Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Liabilities and Shareholders Equity (2016 - 2025)

Sensus Healthcare (SRTS) has 10 years of Liabilities and Shareholders Equity data on record, last reported at $58.3 million in Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity fell 2.61% year-over-year to $58.3 million; the TTM value through Dec 2025 reached $177.4 million, down 25.31%, while the annual FY2024 figure was $62.2 million, 15.74% up from the prior year.
  • Liabilities and Shareholders Equity reached $58.3 million in Q3 2025 per SRTS's latest filing, down from $58.9 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $62.2 million in Q4 2024 and bottomed at $25.6 million in Q3 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $50.4 million, with a median of $54.8 million recorded in 2022.
  • Peak YoY movement for Liabilities and Shareholders Equity: decreased 18.15% in 2021, then surged 113.75% in 2022.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $32.2 million in 2021, then soared by 75.98% to $56.7 million in 2022, then dropped by 5.33% to $53.7 million in 2023, then rose by 15.74% to $62.2 million in 2024, then dropped by 6.23% to $58.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $58.3 million in Q3 2025, $58.9 million in Q2 2025, and $60.2 million in Q1 2025.